IV ozone therapy is a procedure in which a small amount of your blood is drawn, mixed with medical-grade ozone gas, and then reinfused into your bloodstream. The formal name is major autohemotherapy (MAH), and it’s used in integrative and alternative medicine clinics for conditions ranging from chronic pain to inflammatory diseases. It is not approved by the FDA, which considers ozone a toxic gas with no established medical application, though it is practiced widely in parts of Europe, Latin America, and in some private clinics in the United States.
How the Procedure Works
During a session, a practitioner draws roughly 200 mL of blood from a vein, about the same volume as a standard blood donation bag. That blood is collected into a sterile bag and gently mixed with an oxygen-ozone gas mixture. The ozone concentration used for systemic treatments typically falls between 10 and 40 micrograms per milliliter of blood. Within about two minutes, the treated blood is reinfused back into your vein through an IV line.
Concentrations below 10 micrograms per milliliter have little to no biological effect because antioxidants already present in your blood neutralize the ozone entirely. On the other end, concentrations at or above 60 micrograms per milliliter are considered toxic. This narrow therapeutic window is one reason the procedure requires precise equipment, including a calibrated ozone generator and medical-grade oxygen.
What Ozone Does Inside Your Blood
When ozone dissolves in the liquid portion of your blood, it reacts with fats and water to produce hydrogen peroxide and a group of compounds called lipid ozonation products. These create a brief, controlled burst of oxidative stress, essentially a small chemical challenge that triggers your body’s defensive systems to ramp up.
That challenge activates a molecular switch called Nrf2, which tells your cells to produce more of their own antioxidant enzymes. The result is a temporary surge in your body’s natural antioxidant defenses, including enzymes that neutralize free radicals and protect cells from damage. Proponents argue this is the core benefit: rather than delivering an antioxidant from the outside (like a vitamin C supplement), ozone therapy prompts your body to manufacture its own.
In red blood cells specifically, ozone exposure increases a molecule called 2,3-DPG, which makes hemoglobin release oxygen more easily into tissues. This is the same mechanism that helps your body deliver oxygen at high altitude. The idea is that tissues starved of oxygen, whether from poor circulation or chronic disease, get better oxygen delivery after treatment. With repeated sessions, some researchers have proposed that the chemical signals generated reach the bone marrow and stimulate the production of new red blood cells.
Effects on Inflammation and Immune Function
The area with the most research involves ozone’s effects on inflammatory signaling molecules called cytokines. At therapeutic concentrations (20 to 40 micrograms per milliliter), ozone therapy appears to reduce levels of several pro-inflammatory cytokines, particularly IL-6, IL-1β, and TNF-α. These are the same molecules that drive pain and tissue damage in conditions like osteoarthritis and rheumatic diseases. At the same time, ozone may increase levels of anti-inflammatory cytokines like IL-10, shifting the overall immune balance away from chronic inflammation.
There’s an important caveat here: concentration matters a great deal. Research has shown that low-to-moderate ozone concentrations (20 to 40 micrograms per milliliter) reduce inflammatory markers and produce analgesic effects, while high concentrations (60 micrograms per milliliter) actually increase those same inflammatory markers and cause pain. This dose-dependent flip is a defining feature of ozone therapy and underscores why proper dosing is critical.
What the Clinical Evidence Shows
The strongest evidence for ozone therapy clusters around pain reduction and musculoskeletal conditions. A large evidence map reviewing the research found 42 positive associations for pain reduction, with low back pain and improved physical function being the most frequently studied outcomes. For knee osteoarthritis specifically, a meta-analysis found a statistically significant reduction in pain following ozone injections. For low back pain, ozone therapy showed greater efficacy than steroids or placebo at the six-month mark, though the difference wasn’t significant at three months.
For wound healing, the evidence is also notable. In diabetic foot ulcers, ozone therapy combined with standard care improved wound area by roughly 67% compared to standard care alone and reduced the amputation rate by 64%. For inflammation more broadly, the majority of reviewed studies showed positive or potentially positive effects, though some results were inconclusive.
It’s worth being honest about the limitations. Most studies are small, and the overall body of evidence is still considered preliminary by mainstream medical standards. Many trials lack the rigorous double-blinding and large sample sizes that would make results definitive. The conditions where ozone therapy is promoted most aggressively, such as chronic fatigue, autoimmune disease, and general “immune boosting,” have the least clinical evidence behind them.
Safety, Side Effects, and Risks
When performed by a trained practitioner using proper equipment and staying within the established concentration range, ozone therapy is generally tolerated without major side effects. Most people report nothing more than mild fatigue or lightheadedness after a session. However, the procedure is not without serious risks.
The most dangerous potential complication is cerebral air embolism, where gas enters the bloodstream and blocks blood flow to the brain. Case reports have documented severe neurological outcomes, including ischemic brain injuries and lasting cognitive deficits, in patients who were previously healthy before receiving IV ozone. Cardiovascular risks include arrhythmias and vascular injury, particularly in people with pre-existing heart conditions. Respiratory complications can occur if ozone gas is inhaled during the procedure, as ozone is highly damaging to lung tissue.
Several conditions make ozone therapy unsafe:
- G6PD deficiency (favism): People missing this enzyme cannot handle the oxidative stress ozone creates, putting them at risk of severe destruction of red blood cells.
- Pregnancy: Particularly in the first trimester, due to a theoretical risk of mutagenic effects.
- Hyperthyroidism, low platelet counts, or serious cardiovascular instability: These conditions increase the risk of complications.
- ACE inhibitor use: Patients taking these blood pressure medications are advised against the procedure.
What a Typical Treatment Course Looks Like
A single session takes roughly 30 to 60 minutes, including the blood draw, ozone mixing, and reinfusion. Most protocols start at a lower ozone concentration and gradually increase it, often by about 5 micrograms per milliliter per week, until reaching the target dose. For rheumatoid arthritis, for example, Italian treatment guidelines recommend concentrations of 30 to 35 micrograms per milliliter during acute flares and 20 to 25 micrograms per milliliter during quieter periods.
Treatment schedules vary widely depending on the condition and the clinic. Common protocols involve one to three sessions per week over a course of several weeks, sometimes followed by less frequent maintenance sessions. There is no universally standardized protocol, which is one of the challenges in comparing results across different clinics and studies. The total dose per session typically ranges from 1,000 to 2,000 micrograms of ozone, mixed into 150 to 300 mL of blood.
Regulatory Status
The FDA has not approved ozone for any medical use and classifies it as a toxic gas with no known medical application. This means ozone generators cannot be legally marketed as medical devices in the United States for therapeutic purposes. In practice, many clinics operate under the umbrella of integrative or naturopathic medicine, where regulatory oversight varies by state. In contrast, countries like Germany, Italy, Spain, and Cuba have more established frameworks for clinical ozone use, with published treatment guidelines and professional societies overseeing practice standards. The gap between widespread clinical use in some countries and the lack of regulatory approval in others reflects the ongoing tension between preliminary positive research and the absence of large, definitive clinical trials.